Rapid emergence of high-level tigecycline resistance in Escherichia coli strains harbouring blaNDM-5 in vivo

International Journal of Antimicrobial Agents

Volumn 47, Issue 4, 2016, Pages 324-327

  Li, Xi ^a   Mu, Xinli ^a   Yang, Yunxing ^a   Hua, Xiaoting ^a   Yang, Qing ^b   Wang, Nanfei ^a   Du, Xiaoxing ^a   Ruan, Zhi ^a   Shen, Xiaoqiang ^c   Yu, Yunsong ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY   (China)

^c Hangzhou Red Cross Hospital   (China)

Author keywords

Efflux pumps; Escherichia coli; Fitness cost; Tigecycline resistance

Indexed keywords

AMIKACIN; AMPICILLIN; AZTREONAM; CARBAPENEM DERIVATIVE; CEFEPIME; CEFOTETAN; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; ERTAPENEM; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MINOCYCLINE; NITROFURANTOIN; PENICILLIN DERIVATIVE; PIPERACILLIN PLUS TAZOBACTAM; POLYPEPTIDE ANTIBIOTIC AGENT; SULTAMICILLIN; TETRACYCLINE; TIGECYCLINE; TOBRAMYCIN; ANTIINFECTIVE AGENT; BETA LACTAMASE; BETA-LACTAMASE NDM-1;

ADULT; AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BACTERIAL GENE; BACTERIAL GENOME; BACTERIAL STRAIN; BACTERIUM ISOLATE; CASE REPORT; CONTROLLED STUDY; ESCHERICHIA COLI; FEMALE; GENE MUTATION; GENE SEQUENCE; GROWTH RATE; HUMAN; IN VIVO STUDY; LOADING DRUG DOSE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RPSJ GENE; ANALOGS AND DERIVATIVES; DNA MUTATIONAL ANALYSIS; DNA SEQUENCE; DRUG EFFECTS; ENZYMOLOGY; ESCHERICHIA COLI INFECTIONS; GENETICS; GROWTH, DEVELOPMENT AND AGING; LONGITUDINAL STUDY; MICROBIAL SENSITIVITY TEST; MISSENSE MUTATION;

ADULT; AMINO ACID SUBSTITUTION; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; DNA MUTATIONAL ANALYSIS; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; GENOME, BACTERIAL; HUMANS; LONGITUDINAL STUDIES; MICROBIAL SENSITIVITY TESTS; MINOCYCLINE; MUTATION, MISSENSE; SEQUENCE ANALYSIS, DNA;

EID: 84961135889     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2016.01.005     Document Type: Article

References (20)

1. D.M. Livermore Tigecycline: what is it, and where should it be used? J Antimicrob Chemother 56 2005 611 614
2. A. Ruzin, D. Keeney, and P.A. Bradford AdeABC multidrug efflux pump is associated with decreased susceptibility to tigecycline in Acinetobacter calcoaceticus-Acinetobacter baumannii complex J Antimicrob Chemother 59 2007 1001 1004
3. F. McAleese, P. Petersen, A. Ruzin, P.M. Dunman, E. Murphy, S.J. Projan, and et al. A novel MATE family efflux pump contributes to the reduced susceptibility of laboratory-derived Staphylococcus aureus mutants to tigecyclinie Antimicrob Agents Chemother 49 2005 1865 1871
4. Q. Chen, X. Li, H. Zhou, Y. Jiang, Y. Chen, X. Hua, and et al. Decreased susceptibility to tigecycline in Acinetobacter baumannii mediated by a mutation in trm encoding SAM-dependent methyltransferase J Antimicrob Chemother 69 2014 72 76
5. X. Li, L. Liu, J. Ji, Q. Chen, X. Hua, Y. Jiang, and et al. Tigecycline resistance in Acinetobacter baumannii mediated by frameshift mutation in plsC, encoding 1-acyl-sn-glycerol-3-phosphate acyltransferase Eur J Clin Microbiol Infect Dis 34 2015 625 631
6. V. Cattoir, C. Isnard, T. Cosquer, A. Odhiambo, F. Bucquet, F. Guerin, and et al. Genomic analysis of reduced susceptibility to tigecycline in Enterococcus faecium Antimicrob Agents Chemother 59 2015 239 244
7. L. Villa, C. Feudi, D. Fortini, A. Garcia-Fernandez, and A. Carattoli Genomics of KPC-producing Klebsiella pneumoniae sequence type 512 clone highlights the role of RamR and ribosomal S10 protein mutations in conferring tigecycline resistance Antimicrob Agents Chemother 58 2014 1707 1712
8. I.F. Moore, D.W. Hughes, and G.D. Wright Tigecycline is modified by the flavin-dependent monooxygenase TetX Biochemistry 44 2005 11829 11835
9. K.K. Kumarasamy, M.A. Toleman, T.R. Walsh, J. Bagaria, F. Butt, R. Balakrishnan, and et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study Lancet Infect Dis 10 2010 597 602
10. D. Keeney, A. Ruzin, F. McAleese, E. Murphy, and P.A. Bradford MarA-mediated overexpression of the AcrAB efflux pump results in decreased susceptibility to tigecycline in Escherichia coli J Antimicrob Chemother 61 2008 46 53
11. M. Linkevicius, L. Sandegren, and D.I. Andersson Mechanisms and fitness costs of tigecycline resistance in Escherichia coli J Antimicrob Chemother 68 2013 2809 2819
12. Clinical and Laboratory Standards Institute Performance standards for antimicrobial susceptibility testing; twenty-fifth informational supplement. Document M100-S25 2015 CLSI Wayne, PA
13. U.O. Hasdemir, J. Chevalier, P. Nordmann, and J.M. Pages Detection and prevalence of active drug efflux mechanism in various multidrug-resistant Klebsiella pneumoniae strains from Turkey J Clin Microbiol 42 2004 2701 2706
14. A.P. Magiorakos, A. Srinivasan, R.B. Carey, Y. Carmeli, M.E. Falagas, C.G. Giske, and et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance Clin Microbiol Infect 18 2012 268 281
15. NDM-5 carried by an IncX3 plasmid in Escherichia coli sequence type 167 Antimicrob Agents Chemother 58 2014 7548 7552
16. G. Cuzon, R.A. Bonnin, and P. Nordmann First identification of novel NDM carbapenemase, NDM-7, in Escherichia coli in France PLOS ONE 8 2013 e61322
17. M. Deng, M. Zhu, J. Li, S. Bi, Z. Sheng, F. Hu, and et al. Molecular epidemiology and mechanisms of tigecycline resistance in clinical isolates of Acinetobacter baumannii from a Chinese university hospital Antimicrob Agents Chemother 58 2014 297 303
18. T. Spanu, G. De Angelis, M. Cipriani, B. Pedruzzi, T. D'Inzeo, M.A. Cataldo, and et al. In vivo emergence of tigecycline resistance in multidrug-resistant Klebsiella pneumoniae and Escherichia coli Antimicrob Agents Chemother 56 2012 4516 4518
19. G. Werner, S. Gfrorer, C. Fleige, W. Witte, and I. Klare Tigecycline-resistant Enterococcus faecalis strain isolated from a German intensive care unit patient J Antimicrob Chemother 61 2008 1182 1183
20. K. Beabout, T.G. Hammerstrom, A.M. Perez, B.F. Magalhaes, A.G. Prater, T.P. Clements, and et al. The ribosomal S10 protein is a general target for decreased tigecycline susceptibility Antimicrob Agents Chemother 59 2015 5561 5566